Mouse FCs May Contain Lymphoid Progenitor Cells That Have the Capacity to Generate B and T Cells In Vivo.
Institute for Cellular Therapeutics, University of Louisville, Louisville, KY
Meeting: 2017 American Transplant Congress
Abstract number: 208
Keywords: Bone marrow transplantation
Session Information
Session Name: Concurrent Session: Basic Transplant Tolerance I
Session Type: Concurrent Session
Date: Monday, May 1, 2017
Session Time: 2:30pm-4:00pm
Presentation Time: 3:06pm-3:18pm
Location: E350
CD8+/TCR– facilitating cells (FCs) are a rare bone marrow-derived cell population that enhances engraftment of hematopoietic stem cells (HSC) in major histocompatibility complex disparate recipients without causing graft versus host disease. Both human and mouse FC exert a number of regulatory effects on HSC, including the enhancement of survival and clonogenicity of HSCs and the induction of regulatory cells including IL-10-producing Tr1 cells, Tregs, and Bregs. In the present study we evaluated the ontogeny of mouse FCs after infusion. FACS sorted 200,000 FCs from C57BL/6 (45.2) mice were transplanted to B6SJL (45.1) mice conditioned with 500cGy. Donor FC-derived cells were analyzed three weeks later in recipient bone marrow, spleen, thymus and lymph nodes (LN). We found that donor FCs do not retain their CD8+TCR– phenotype and were mainly found in spleen and lymph-nodes (LN). The majority of donor cells in spleen and LN were CD19+ B cells, whereas in the thymus the pre-dominant phenotype was CD4+CD8+T cells. This suggests that FCs contain lymphoid progenitor cells that differentiate into either B or T cells depending upon the microenvironment. Donor derived myeloid cells were also found in low frequencies. To better characterize B cell progenitors in mouse FCs, 50,000 CD8+TCR– FCs sorted from 6-8 week oldC57BL/6 mice were stained with an eight-color immunophenotyping panel composed of CD8, TCRαβ, TCRγδ, B220, CD43, CD93, CD24, BP1 and IgM. Among CD8+TCR– total FC (n=8), 58% were pro-B B cell progenitors (B220+CD43+CD24+IgM–BP1–), 1.4 % were immature B cell progenitors (B220+CD43–CD24+IgM+CD93+), and only 0.3% were pre-B cell progenitors (B220+CD43–CD24+IgM–BP1+).
To exclude the contribution of preferential proliferation of pre-existing CD19+ (mature B cells) in the FCs, we transferred sorted CD19-depleted FCs. Depletion of the CD19+ expressing cells from FCs did not affect the predominance of CD19+ cells in spleen and LNs, supporting that FCs may contain lymphoid progenitors which differentiate into CD19+ B cells. Interestingly, a more pre-dominant T cell population was observed at five weeks, and about 5% of CD4+T cells expressed Foxp3. Our study shows for the first time that FCs may contain common lymphoid progenitor cells that give rise to B cells, T cells and regulatory T cells in nonmyeloablatively conditioned congenic mice.
CITATION INFORMATION: Chhabra A, Wen Y, Huang Y, Xu H, Merchak A, Ildstad S. Mouse FCs May Contain Lymphoid Progenitor Cells That Have the Capacity to Generate B and T Cells In Vivo. Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Chhabra A, Wen Y, Huang Y, Xu H, Merchak A, Ildstad S. Mouse FCs May Contain Lymphoid Progenitor Cells That Have the Capacity to Generate B and T Cells In Vivo. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/mouse-fcs-may-contain-lymphoid-progenitor-cells-that-have-the-capacity-to-generate-b-and-t-cells-in-vivo/. Accessed November 24, 2024.« Back to 2017 American Transplant Congress